Altimmune to Participate in the Guggenheim SMID Cap Biotech Conference

Rhea-AI Summary

Altimmune (Nasdaq: ALT), a clinical-stage biopharmaceutical company, has announced its upcoming participation in the Guggenheim SMID Cap Biotech Conference. The company's management team will engage in a fireside chat scheduled for Wednesday, February 5, 2025, at 9:30 a.m. EST.

Interested parties can access the session through a webcast available in the Events section of the Altimmune website. This participation represents an opportunity for investors and stakeholders to gain insights into the company's developments and strategic direction.

News Market Reaction – ALT

+0.29%

+0.29% Session move

In the trading session that priced this news, ALT gained 0.29%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GAITHERSBURG, Md., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate in a fireside chat at the Guggenheim SMID Cap Biotech Conference. Details are as follows:

	Conference:	Guggenheim SMID Cap Biotech Conference
	Date/Time:	Wednesday, February 5, 2025, at 9:30 a.m. EST

The session will be webcast and can be accessed by visiting the Events section of the Altimmune website.

About Altimmune

Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH. For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Company Contact:
Greg Weaver
Chief Financial Officer
Phone: 240-654-1450
ir@altimmune.com

Investor Contact:
Lee Roth
Burns McClellan
Phone: 646-382-3403
lroth@burnsmc.com

Media Contact:
Danielle Cantey
Inizio Evoke, Biotech
Phone: 619-826-4657
Danielle.cantey@inizioevoke.com

FAQ

When is Altimmune (ALT) presenting at the Guggenheim SMID Cap Biotech Conference 2025?

Altimmune will present at the Guggenheim SMID Cap Biotech Conference on Wednesday, February 5, 2025, at 9:30 a.m. EST.

How can investors watch Altimmune's (ALT) presentation at the Guggenheim Conference?

Investors can watch Altimmune's presentation via webcast by visiting the Events section of the Altimmune website.

What type of presentation will Altimmune (ALT) give at the Guggenheim SMID Cap Conference?

Altimmune's management team will participate in a fireside chat format presentation at the conference.

Where is the Altimmune (ALT) Guggenheim Conference presentation taking place?

The presentation is part of the Guggenheim SMID Cap Biotech Conference, though the specific location was not disclosed in the announcement.